伊藤　晴國Ito, Harukuni

カウンセル

東京 + 81.3.6800.1812

Connect:

共有

伊藤晴國は、弁護士登録以来一貫して、特許をはじめとする知的財産権に関連する紛争および商取引を主たるプラクティス分野としており、これらの分野について豊富な経験を有しています。

国内外の大手企業を代理して、エレクトロニクス、自動車、機械、製薬等、様々な技術分野における特許訴訟および特許庁における審判手続を取り扱った経験を多数有するほか、商品等主体混同行為、商品形態模倣行為、営業秘密侵害行為、営業誹謗行為等、様々な類型の不正競争行為についても訴訟経験を有しています。

また、様々な類型の国際商取引に関する契約、特に技術ライセンス、共同研究開発といったテクノロジー関連取引の契約書作成およびアドバイスについて豊富な実務経験を有しています。

とりわけ近時は、ライフサイエンス分野の取引および紛争案件に注力しており、医薬品、医療機器および再生医療等製品に関するライセンス、販売、販促、受託製造、その他の取引の契約書の作成・交渉を多数手掛けるほか、医薬ライセンス契約に関する国際仲裁を複数取り扱っています。

伊藤晴國は、契約上の請求権に関する訴訟、労働訴訟、株主代表訴訟等、知的財産権訴訟以外の一般訴訟についても幅広い経験を有しています。また、日本語と英語による業務が可能です。

担当案件

  • Global pharmaceutical client wins ICC arbitration arising from collaboration disputeJones Day successfully defended a multinational, pharmaceutical client against a $300-plus million breach-of-contract claim arising from a collaboration agreement and that alleged among other things a failure to use commercially reasonable efforts.
  • Japanese consortium led by Suntory partners with Anellotech to develop plastics recycling technologyJones Day advised a consortium jointly established by Suntory and other Japanese companies in connection with its partnering with Anellotech, Inc., a U.S.-based biochemical company, in the development of a plastics recycling technology.
  • Global pharmaceutical company seeks over $1 billion in ICC arbitration related to licensing agreementJones Day successfully represented a global pharmaceutical company seeking over $1 billion in a licensing agreement dispute over royalty payments and the application of U.S. Supreme Court decisions in Brulotte and Kimble, among other claims.
  • Pharmaceutical company defends ICC arbitration relating to licensing agreementJones Day is representing a multinational, pharmaceutical company in an ICC arbitration arising from a dispute over the term of a license agreement and when royalty payment obligations ceased.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • TonenGeneral Sekiyu combines with JX GroupJones Day advised TonenGeneral Sekiyu K.K. in connection with the business integration with JX Group, which forms the largest oil refiner in Japan.
  • Riverside acquires Y InternationalJones Day advised The Riverside Company in connection with its acquisition of Y International, Inc., a Tokyo-based bicycle retailer with 29 company-owned stores across Japan with a particular focus on metropolitan Tokyo.
  • SDS Biotech acquires Sree RamcidesJones Day advised SDS Biotech K.K., a subsidiary of Idemitsu Kosan Co., Ltd., in connection with the acquisition of 65% of the shares of Sree Ramcides Chemicals Pvt. Ltd., a Chennai-based agrichemicals manufacturer, from ePlanet Capital and certain minority shareholders.
  • Hon Hai Precision acquires LCD-related patent portfolio from NEC Corporation for ¥9.5 billion (US$110 million)Jones Day advised Hon Hai Precision Industry Co., Ltd. (also known as Foxconn), the world's largest EMS (Electronics Manufacturing Service) provider headquartered in Taiwan, in its purchase through its subsidiary, Gold Charm Ltd., of an LCD-related patent portfolio from NEC Corporation for ¥9.5 billion (approximately US$110 million).
  • RHJ International sells its 77.9% ownership of Niles Co. to Valeo for ¥15.4 billion (€135 million)Jones Day advised RHJ International SA in its sale of its 77.9% interest in Niles Co., Ltd., a Japanese auto parts manufacturer, to Valeo SA, a worldwide leader in the interior controls market, for a total cash consideration of ¥15.4 billion (€135 million).
  • Toray Industries and TonenGeneral Sekiyu K. K. form joint ventureJones Day advised Toray Industries, Inc. in its formation of a joint venture with TonenGeneral Sekiyu K. K. through a new contribution of capital into Tonen Specialty Separator Godo Kaisha to develop, manufacture and sell lithium ion battery separator film.
  • Sumitomo Corporation acquires 35% stake in Hachette FujingahoJones Day advised Sumitomo Corporation in its strategic alliance with and acquisition of a 35% stake in Hachette Fujingaho, a subsidiary of Lagardère SCA.
  • Nissin Food acquires 33.5% stake in Russia's AnglesideJones Day represented Nissin Foods Holdings Co., Ltd. in connection with the acquisition of a roughly 15% stake in Angleside Ltd, the holding company of Mareven Food Central, the leading instant noodle manufacturer in Russia, for approximately ¥9 billion ($100 million).
  • SCHOTT acquires majority share in Japan-based Moritex, expanding fiber optic operations into AsiaJones Day advised SCHOTT AG in its Yen 7.28 billion ($82 million) acquisition of a controlling interest in Tokyo-based Moritex Corporation.
    •

    April 2021 Newsletters

    Vital Signs: Digital Health Law Update Spring 2021

    April 2021 ニュースレター

    Vital Signs: デジタルヘルス法アップデート | 2021年春

    January 2021 ニュースレター

    Vital Signs: デジタルヘルス法アップデート | 2021年冬

    November 2020 Jones Day Publications

    Global Legal Update Vol. 61 | 2020年11月号

    November 2020 Japan Newsletter

    Japan Legal Update Vol. 53 | 2020年秋号

    October 2020 ニュースレター

    Vital Signs: デジタルヘルス法アップデート | 2020年秋

    September 2020 Jones Day Publications

    Global Legal Update Vol. 59 | 2020年9月号

    August 2020 ニュースレター

    Vital Signs: デジタルヘルス法アップデート | 2020年夏

    August 2020 Jones Day Publications

    Japan Legal Update Vol. 52 | 2020年夏号

    April 2020 ニュースレター

    Vital Signs: デジタルヘルス法アップデート | 2020年春
    インサイト一覧

    セミナー・講演

    • October 2020
      医薬品企業法務研究会：英文供給契約／コモンローの視点から見た不可抗力条項
    • August 2019
      医薬品企業法務研究会：実践的な英文ライセンス契約
    • November 2013
      インドM&Aセミナー
    *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。